Abstract
Bacterial meningitis remains a life-threatening infection at any age, and prompt, adequate treatment is of great prognostic importance. Due to the special features of the meninges as a site of infection, many problems are associated with antimicrobial therapy. Approximately 80 % of the patients with bacterial meningitis belong to the pediatric age group, and the three principal pathogens are Haemophilus influenzae type b,Neisseria meningitidis and Streptococcus pneumoniae.The diagnostic requirements essential for satisfactory management are defined and the antibiotic therapy of meningitis is discussed in detail. Data obtained from both experimental and clinical meningitis are indicative that a minimum bactericidal titre of 1∶10 should be achieved in the cerebrospinal fluid for optimal therapeutic results. Recommendations are given for specific antimicrobial treatment according to patient's age and causative organism, as well as guidelines for further lumbar punctures, duration of therapy and prophylaxis, with emphasis on the important role of the newer cephalosporin compounds in the treatment of meningitis.
Similar content being viewed by others
References
Schaad, U. B.: Antibiotikatherapie der bakteriellen Meningitis. Therapeutische Umschau 1984, 41: 335–341.
McCracken, G. H., Jr.: Management of bacterial meningitis; current status and future prospects. American Journal of Medicine 1984, 74: 215–223.
Scheid, W. M.: Theoretical and practical considerations of antibiotic therapy for bacterial meningitis. Pediatric Infectious Disease 1985, 4: 74–83.
Simberkoff, M. S., Moldover, N. H., Rahal, J. J.: Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. Journal of Laboratory and Clinical Medicine 1980, 95: 362–372.
Zwahlen, A., Nydegger, U. E., Vaudaux, P., Lambert, P.-H., Waldvogel, F. A.: Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. Journal of Infectious Diseases 1982, 145: 635–646.
Barling, R. W. A., Selkon, J. B.: The penetration of antibiotics into cerebrospinal fluid and brain tissue. Journal of Antimicrobial Chemotherapy 1978, 4: 203–227.
Richards, M. L., Prince, R. A., Kenaley, K. A., Johnson, J. A., LeFrock, J. L.: Antimicrobial penetration into cerebrospinal fluid. Drug Intelligence and Clinical Pharmacy 1981, 15: 341–368.
Täuber, M. G., Sande, M. A.: Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits. Infection 1984, 12: S3-S8.
Täuber, M. G., Khayam-Bashi, H., Sande, M. A.: Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. Journal of Infectious Diseases 1985, 151: 528–534.
Schaad, U. B., McCracken, G. H., Jr.: Pharmacologiec basis for antimicrobial therapy of neonatal meningitis. Helvetica Paediatrica Acta 1981, 365: 19–30.
McCabe, W. R.: Empiric therapy for bacterial meningitis. Reviews of Infectious Diseases 1983, 5: S74-S84.
Schaad, U. B., McCracken, G. H., Jr., Look, C. A., Thomas, M. L.: Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. Journal of Infectious Diseases 1981, 143: 156–163.
Kobelt, R., Schaad, U. B.: Prospektive Evaluation von Coagglutination und Latex-Agglutination in der Diagnostik der bakteriellen Meningitiden im Kindesalter. Schweizerische Medizinische Wochenschrift 1986,116: 431–440.
Teele, D. W., Dashefsky, B., Rakusan, T., Klein, J. O.: Meningitis after lumbar puncture in children with bacteremia. New England Journal of Medicine 1981, 305: 1079–1081.
Feldman, W. E., Ginsburg, C. M., McCracken, G. H., Jr., Allen, D., Ahmann, P., Graham, J., Graham, L.: Relation of concentrations ofHaemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis. Journal of Pediatrics 1982, 100: 209–212.
Smith, A. L.: Antibiotic resistance in haemophilus influenzae. Pediatric Infectious Diseases 1983, 2: 352–355.
Tuazon, C. U., Shamsuddin, D., Miller, H.: Antibiotic susceptibility and synergy of clinical isolates ofListeria monocytogenes. Antimicrobial Agents and Chemotherapy 1982, 21: 525–527.
Laferriere, C. I., Marks, M. I.: Chloramphenicol: properties and clinical use. Pediatric Infectious Disease 1982, 1: 257–264.
Young, L. S.: Problems in determining the efficacy of aminoglycosides. Reviews of Infectious Diseases 1983, 5: S250-S257.
Dajani, A. S.: Antibiotic-resistant pneumococci. Pediatric Infectious Disease 1982, 1: 143–144.
Neu, H. C.: The new beta-lactamase-stable cephalosporins. Annals of Internal Medicine 1982, 97: 408–419.
Schaad, U. B.: The cephalosporin compounds in severe neonatal infection. European Journal of Pediatrics 1984, 141: 143–146.
Schaad, U. B., Krucko, J., Pfenninger, J.: An extended experience with cefuroxime therapy of childhood bacterial meningitis. Pediatric Infectious Disease 1984, 3: 410–416.
Baumgartner, E. T., Augustine, A., Steele, R. W.: Bacterial meningitis in older neonates. American Journal of Diseases in Children 1983, 137: 1052–1054.
Martin, E.: Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children. European Journal of Clinical Microbiology 1983, 2: 509–515.
Schaad, U. B., Nelson, J. D., McCracken, G. H., Jr.: Recrudescence and relapse in bacterial meningitis of childhood. Pediatrics 1981, 67: 188–195.
Lin, T.-Y., Nelson, J. D., McCracken, G. H., Jr.: Fever during treatment for bacterial meningitis. Pediatric Infectious Disease 1984, 3: 319–322.
Klein, J. O.: The epidemiology of pneumococcal disease in infants and children. Reviews of Infectious Diseases 1981, 3: 246–253.
Schaad, U. B.: Chemoprophylaxis for the prevention of bacterial meningitis. Infection 1984, 12: S65-S68.
Schaad, U. B.: Chemoprophylaxis of bacterial meningitis. Journal of Antimicrobial Chemotherapy 1985, 15: 131–133.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schaad, U.B. Treatment of bacterial meningitis. Eur. J, Clin. Microbiol. 5, 492–497 (1986). https://doi.org/10.1007/BF02017689
Issue Date:
DOI: https://doi.org/10.1007/BF02017689